The advantages and disadvantages of using heparin as the sole anticoagulant during the first thirty days after acute myocardial infarction.
D056988:Anterior Wall Myocardial Infarction; D000925:Anticoagulants; D002318:Cardiovascular Diseases; D006493:Heparin / Q000628:therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*
D000925:Anticoagulants; D006493:Heparin
HEPARIN/therapy; MYOCARDIAL INFARCT/therapy